ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 603578 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 603578; 2) Community: the network communities that were significantly associated with the response to NSC 603578; 3) Molecule: the relationships between components within communities and NSC 603578; 4) MDR: the compounds that were significantly associated with the NSC 603578.

NSC Compound Enrichment Correlation
NSC 100880 Camptothecin 0.0297837393005856 0.62191887
NSC 105014 Cladribine 0.0297837393005856 0.39425582
NSC 119915 3-(4,5,6-trihydroxy-3-oxo-3H-xanthen-9-yl)propanoic acid 0.0297837393005856 0.16319545
NSC 148790 Card-20(22)-enolide, 16-(acetyloxy)-3,14-dihydroxy-, (3.beta.,5.beta.,16.beta.)- (9CI) 0.0297837393005856 0.45742299
NSC 163424 4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- 0.0297837393005856 0.21863315
NSC 18805 .gamma.-Thujaplicine 0.0297837393005856 0.33610292
NSC 22709 v-Triazolo[4,5-d]pyrimidin-7-ol 0.0297837393005856 0.37136817
NSC 328410 Camptothecin Derivative 0.0297837393005856 0.44789549
NSC 328477 3'-Chloro-3-nitro-o-salicylotoluidide 0.0297837393005856 0.2241379
NSC 363813 Platinum, tetrachloro(1,2-cyclohexanediamine-N,N')-, [OC-6-22-(1S-trans)]- 0.0297837393005856 0.577288
Total:85  Current:51    [First] [Prev] [Next] [Last]